Skip to content
Janssen Pharmaceuticals

Janssen Pharmaceuticals

YTX-7739 is a small molecule that acts as an alpha synuclein pathology inhibitor, potentially inhibiting the aggregation of alpha-synuclein and thus halting the progression of diseases like Parkinson's.

Cart 0

Your cart is currently empty.

Start Shopping